Literature DB >> 287196

Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

R C Bucknall, G Balint, R L Dawkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 287196     DOI： 10.3109/03009747909108245

Source DB:  PubMed          Journal:  Scand J Rheumatol Suppl        ISSN： 0301-3847


× No keyword cloud information.
  4 in total

Review 1.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 2.  Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.

Authors:  I A Jaffe
Journal:  Springer Semin Immunopathol       Date:  1981

3.  Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.

Authors:  A Vincent; J Newsom-Davis
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

4.  Effect of DL-penicillamine on the aorta of growing chickens. Ultrastructural and biochemical studies.

Authors:  I Pasquali Ronchetti; C Fornieri; M Baccarani Contri; D Quaglino; E Caselgrandi
Journal:  Am J Pathol       Date:  1986-09       Impact factor: 4.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.